CTMC Webinar

Adverse Event Reporting and Safety Monitoring

Presented by Robert Silbergleit, MD

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material (April 15-October 21, 2016) for a maximum of 10 AMA PRA Category 1 Credit(s)™. Each webinar is eligible for up to 1  AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Direct URL to access Blue Jeans: https://primetime.bluejeans.com/a2m/live-event/lo38016

Joining with a mobile device? Android and iOS apps are available. Enter event ID lo38016

-----------------------------------------------------------------------------------------------------------------------------------

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute, the University of Iowa, Los Angeles BioMed, and the University of Michigan. The American Academy of Neurology Institute is accredited by the ACCME to provide continuing medical education for physicians.

Objectives of the webinar series

1.Participants will improve their knowledge of the design and conduct of clinical trials in the neurosciences;

2.Analyze the information presented; and

3.Integrate relevant content into the design and conduct of clinical trials.

Core competencies

1.Analytic/Assessment skills

2.Public Health Science skills

Previous CTMC webinars are archived on the course website https://nett.umich.edu/training/ctmc

The NINDS Clinical Trials Methodology Course is supported by the NIH-NINDS: R25 NS088248 and is administered by the University of Michigan, the University of Iowa, and Los Angeles BioMed. Additional support is provided by the American Academy of Neurology.

Questions? Email NINDS-CTMC-Info@umich.edu